We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Urology

Journal Scan / Research · February 22, 2017

The Number of Cycles of Collagenase Clostridium histolyticum Impacts Outcomes in Peyronie's Disease



Additional Info

Disclosure statements are available on the authors' profiles:

Impact of Number of Cycles of Collagenase Clostridium Histolyticum on Outcomes in Patients With Peyronie's Disease
Urology 2017 Feb 01;100(xx)125-130, J Anaissie, FA Yafi, KJ DeLay, EJ Traore, SC Sikka, WJ Hellstrom

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading